Skip to Content

223 (Lithium carbonate extended release 300 mg)

Pill imprint 223 has been identified as Lithium carbonate extended release 300 mg.

Lithium is used in the treatment of bipolar disorder; borderline personality disorder; depression; cyclothymic disorder; intermittent explosive disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.